nintedanib
Showing 26 - 50 of 81
Idiopathic Pulmonary Fibrosis Trial in Seongnam-si (DWN12088, Pirfenidone, Nintedanib)
Completed
- Idiopathic Pulmonary Fibrosis
- DWN12088
- +2 more
-
Seongnam-si, Korea, Republic ofCha Unitersity Bundang Medical Center
Sep 22, 2021
Progressive Fibrosing Interstitial Lung Disease Trial in Morgantown (Nintedanib, Placebo)
Not yet recruiting
- Progressive Fibrosing Interstitial Lung Disease
- Nintedanib
- Placebo
-
Morgantown, West VirginiaWest Virginia University Hospital
Sep 29, 2021
Lung Cancer, Lung Metastases Trial in United States (Nintedanib, Prednisone, Placebo)
Active, not recruiting
- Lung Cancer
- Lung Metastases
- Nintedanib
- +2 more
-
Boston, Massachusetts
- +11 more
Jul 19, 2022
All-Case Surveillance of Ofev in Patients With IPF in Japan
Recruiting
- Idiopathic Pulmonary Fibrosis
- Nintedanib
-
Multiple Locations, Japan(unnamed)
Jan 23, 2023
Based on Medical Records That Looks at Characteristics of
Completed
- Idiopathic Pulmonary Fibrosis
- Nintedanib
- +2 more
-
Plymouth, PennsylvaniaPlymouth Meeting
Nov 12, 2021
INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients
Recruiting
- Lung Diseases, Interstitial
- Nintedanib
-
Aachen, Germany
- +19 more
Jul 26, 2022
Cancer of Pancreas Trial in Dallas (Nintedanib)
Recruiting
- Cancer of Pancreas
- Nintedanib
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jul 29, 2021
Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases
Active, not recruiting
- Lung Diseases, Interstitial
- Nintedanib
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023
Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)
Active, not recruiting
- Uterine Cervical Neoplasms
- Nintedanib
- Placebo
-
Bruxelles, Belgium
- +31 more
Mar 1, 2022
Lung Diseases, Interstitial Trial in Worldwide (Nintedanib (Ofev®), Placebo)
Completed
- Lung Diseases, Interstitial
- Nintedanib
- Placebo
-
Los Angeles, California
- +42 more
Jan 11, 2023
Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Active, not recruiting
- Stage IB Non-Small Cell Lung Carcinoma AJCC v7
- +4 more
- Cisplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 4, 2022
NSCLC Trial in France, Germany (Docetaxel, Nintedanib)
Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)
Completed
- Esophagogastric Adenocarcinoma
- Nintedanib
-
Basking Ridge, New Jersey
- +5 more
Dec 30, 2020
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal
Recruiting
- Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
- +4 more
- Azacitidine
- +2 more
-
Chicago, IllinoisNorthwestern University
Apr 30, 2021
HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)
Completed
- HNSCC
- Head and Neck Neoplasms
- BYL719
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 27, 2022
Cutaneous Malignant Melanoma Trial in Germany (Nintedanib, Nintedanib-Placebo, Paclitaxel)
Completed
- Cutaneous Malignant Melanoma
- Nintedanib
- +2 more
-
Essen, NRW, Germany
- +9 more
Oct 13, 2020
Idiopathic Pulmonary Fibrosis Trial in United States (Nintedanib, Pulmonary rehabilitation program)
Terminated
- Idiopathic Pulmonary Fibrosis
- Nintedanib
- Pulmonary rehabilitation program
-
Birmingham, Alabama
- +18 more
May 14, 2021
Patients With Any Advanced Solid Tumors Trial in Villejuif (Nintedanib, Pembrolizumab)
Recruiting
- Patients With Any Advanced Solid Tumors
- Nintedanib
- Pembrolizumab
-
Villejuif, Val De Marne, FranceGustave Roussy
Apr 6, 2020
Lung Diseases, Interstitial Trial in Worldwide (Nintedanib)
Completed
- Lung Diseases, Interstitial
- Nintedanib
-
Birmingham, Alabama
- +120 more
Sep 21, 2022
Lung Diseases, Interstitial Trial in Worldwide (Nintedanib)
Completed
- Lung Diseases, Interstitial
- Nintedanib
-
Birmingham, Alabama
- +158 more
Jan 24, 2023
(NIS) Collecting Experiences For IPF in Taiwan
Medullary Thyroid Cancer (MTC), Differentiated Thyroid Cancer (DTC) Trial in Worldwide (Nintedanib, Placebo)
Completed
- Medullary Thyroid Cancer (MTC)
- Differentiated Thyroid Cancer (DTC)
- Nintedanib
- Placebo
-
Brugge, Belgium
- +26 more
Jul 30, 2020
Lung Non-Squamous Non-Small Cell Carcinoma, Radiation-Induced Pneumonitis, Stage II Lung Non-Small Cell Cancer AJCC v7 Trial in
Terminated
- Lung Non-Squamous Non-Small Cell Carcinoma
- +8 more
- Durvalumab
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 23, 2020